Cell adhesion-mediated radioresistance revisited

References

• Akalu A, Roth J M, Caunt M, Policarpio D, Liebes L, Brooks P C. Inhibition of angiogenesis and tumor metastasis by targeting a matrix immobilized cryptic extracellular matrix epitope in laminin. Cancer Research 2007; 67: 4353–4363
   PubMed Web of Science ®Google Scholar
• Andratschke N H, Nieder C, Price R E, Rivera B, Ang K K. Potential role of growth factors in diminishing radiation therapy neural tissue injury. Seminars in Oncology 2005; 32: S67–70
   PubMed Web of Science ®Google Scholar
• Barcellos-Hoff M H, Park C, Wright E G. Radiation and the microenvironment – tumorigenesis and therapy. Nature Reviews Cancer 2005; 5: 867–875
   PubMed Web of Science ®Google Scholar
• Barendsen G W. Influence of radiation quality on the effectiveness of small doses for induction of reproductive death and chromosome aberrations in mammalian cells. International Journal of Radiation Biology and related studies in Physics, Chemistry, and Medicine 1979; 36: 49–63
   PubMed Web of Science ®Google Scholar
• Barendsen G W. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. International Journal of Radiation Oncology Biology Physics 1982; 8: 1981–1997
   PubMed Web of Science ®Google Scholar
• Baselga J. A review of EGFR targeted therapy. Clinical Advances in Hematology & Oncology 2003; 1: 218–219
   PubMedGoogle Scholar
• Baumann M, Krause M, Dikomey E, Dittmann K, Dorr W, Kasten-Pisula U, Rodemann H P. EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms. Radiotherapy and Oncology 2007; 83: 238–248
   PubMed Web of Science ®Google Scholar
• Baumann M, Krause M, Zips D, Petersen C, Dittmann K, Dorr W, Rodemann H P. Molecular targeting in radiotherapy of lung cancer. Lung Cancer 2004; 45(Suppl 2)S187–197
   PubMedGoogle Scholar
• Bentzen S M, Harari P M, Bernier J. Exploitable mechanisms for combining drugs with radiation: Concepts, achievements and future directions. Nature Clinical Practice. Oncology 2007; 4: 172–180
   PubMed Web of Science ®Google Scholar
• Bernhard E J, McKenna W G, Muschel R J. Radiosensitivity and the cell cycle. Cancer Journal from Scientific American 1999; 5: 194–204
   PubMed Web of Science ®Google Scholar
• Bissell M J, Kenny P A, Radisky D C. Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes. Cold Spring Harbor Symposia on Quantitative Biology 2005; 70: 343–356
   PubMedGoogle Scholar
• Bonner J A, Harari P M, Giralt J, Azarnia N, Shin D M, Cohen R B, Jones C U, Sur R, Raben D, Jassem J, Ove R, Kies M S, Baselga J, Youssoufian H, Amellal N, Rowinsky E K, Ang K K. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. New England Journal of Medicine 2006; 354: 567–578
   PubMed Web of Science ®Google Scholar
• Boyle R G, Travers S. Hypoxia: Targeting the tumour. Anti-Cancer Agents in Medicinal Chemistry 2006; 6: 281–286
   PubMedGoogle Scholar
• Brakebusch C, Bouvard D, Stanchi F, Sakai T, Fassler R. Integrins in invasive growth. Journal of Clinical Investigation 2002; 109: 999–1006
   PubMed Web of Science ®Google Scholar
• Brown C K, Khodarev N N, Yu J, Moo-Young T, Labay E, Darga T E, Posner M C, Weichselbaum R R, Mauceri H J. Glioblastoma cells block radiation-induced programmed cell death of endothelial cells. FEBS Letters 2004; 565: 167–170
   PubMed Web of Science ®Google Scholar
• Buttery R C, Rintoul R C, Sethi T. Small cell lung cancer: The importance of the extracellular matrix. International Journal of Biochemistry & Cell Biology 2004; 36: 1154–1160
   PubMed Web of Science ®Google Scholar
• Carver L A, Schnitzer J E. Caveolae: Mining little caves for new cancer targets. Nature Reviews Cancer 2003; 3: 571–581
   PubMed Web of Science ®Google Scholar
• Cordes N. Overexpression of hyperactive integrin-linked kinase leads to increased cellular radiosensitivity. Cancer Research 2004; 64: 5683–5692
   PubMed Web of Science ®Google Scholar
• Cordes N. Integrin-mediated cell-matrix interactions for prosurvival and antiapoptotic signaling after genotoxic injury. Cancer Letters 2006; 242: 11–19
   PubMed Web of Science ®Google Scholar
• Cordes N, Frick S, Brunner T B, Pilarsky C, Grützmann R, Sipos B, Klöppel G, McKenna W G, Bernhard E J. Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of Caveolin-1. Oncogene 2007, 2007 April 30 [epub ahead of print]; DOI:10.1038/sj.onc.1210498
   Web of Science ®Google Scholar
• Cordes N, Meineke V. Cell adhesion-mediated radioresistance (CAM-RR). Extracellular matrix-dependent improvement of cell survival in human tumor and normal cells in vitro. Strahlentherapie und Onkologie 2003; 179: 337–344
   PubMed Web of Science ®Google Scholar
• Cordes N, Park C C. Betal integrin as a molecular therapeutic target. Int J Radiat Biol in press, (TRAB-2007-IJRB-0075.R2)
   Google Scholar
• Cordes N, Seidler J, Durzok R, Geinitz H, Brakebusch C. Beta1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury. Oncogene 2006; 25: 1378–1390
   PubMed Web of Science ®Google Scholar
• Cordes N, van Beuningen D. Cell adhesion to the extracellular matrix protein fibronectin modulates radiation-dependent G2 phase arrest involving integrin-linked kinase (ILK) and glycogen synthase kinase-3beta (GSK-3beta) in vitro. British Journal of Cancer 2003; 88: 1470–1479
   PubMed Web of Science ®Google Scholar
• Cordes N, van Beuningen D. Arrest of human lung fibroblasts in G2 phase after irradiation is regulated by converging phosphatidylinositol-3 kinase and beta1-integrin signaling in vitro. International Journal of Radiation Oncology Biology Physics 2004; 58: 453–462
   PubMed Web of Science ®Google Scholar
• Cretu A, Roth J M, Caunt M, Akalu A, Policarpio D, Formenti S, Gagne P, Liebes L, Brooks P C. Disruption of endothelial cell interactions with the novel HU177 cryptic collagen epitope inhibits angiogenesis. Clinical Cancer Research 2007; 13: 3068–3078
   PubMed Web of Science ®Google Scholar
• Damiano J S. Integrins as novel drug targets for overcoming innate drug resistance. Current Cancer Drug Targets 2002; 2: 37–43
   PubMed Web of Science ®Google Scholar
• Damiano J S, Reed J C. CARD proteins as therapeutic targets in cancer. Current Drug Targets 2004; 5: 367–374
   PubMed Web of Science ®Google Scholar
• Danen E H. Integrins: regulators of tissue function and cancer progression. Current Pharmaceutical Design 2005; 11: 881–891
   PubMed Web of Science ®Google Scholar
• Davis G E, Senger D R. Endothelial extracellular matrix: Biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circulation Research 2005; 97: 1093–1107
   PubMed Web of Science ®Google Scholar
• Dittmann K, Mayer C, Fehrenbacher B, Schaller M, Raju U, Milas L, Chen D J, Kehlbach R, Rodemann H P. Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. Journal of Biological Chemistry 2005a; 280: 31182–31189
   PubMed Web of Science ®Google Scholar
• Dittmann K, Mayer C, Rodemann H P. Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity. Radiotherapy and Oncology 2005b; 76: 157–161
   PubMed Web of Science ®Google Scholar
• Eble J A, Haier J. Integrins in cancer treatment. Current Cancer Drug Targets 2006; 6: 89–105
   PubMed Web of Science ®Google Scholar
• Eke I, Sandfort V, Mischkus A, Baumann M, Cordes N. Antiproliferative effects of EGFR tyrosine kinase inhibition and radiation-induced genotoxic injury are attenuated by adhesion to fibronectin. Radiotherapy and Oncology 2006; 80: 178–184
   PubMed Web of Science ®Google Scholar
• Elkind M M, Sutton-Gilbert H, Moses W B, Kamper C. Sub-lethal and lethal radiation damage. Nature 1967; 214: 1088–1092
   PubMed Web of Science ®Google Scholar
• Elliott T, Sethi T. Integrins and extracellular matrix: A novel mechanism of multidrug resistance. Expert Review of Anticancer Therapy 2002; 2: 449–459
   PubMedGoogle Scholar
• Estrugo D, Fischer A, Hess F, Scherthan H, Belka C, Cordes N. Ligand Bound beta1 Integrins Inhibit Procaspase-8 for Mediating Cell Adhesion-Mediated Drug and Radiation Resistance in Human Leukemia Cells. PLoS ONE 2007; 2: e269
   PubMed Web of Science ®Google Scholar
• Fletcher L, Muschel R J. The centrosome and the DNA damage induced checkpoint. Cancer Letters 2006; 243: 1–8
   PubMed Web of Science ®Google Scholar
• Fowlkes J L, Winkler M K. Exploring the interface between metallo-proteinase activity and growth factor and cytokine bioavailability. Cytokine & Growth Factor Reviews 2002; 13: 277–287
   PubMed Web of Science ®Google Scholar
• Fuks Z, Vlodavsky I, Andreeff M, McLoughlin M, Haimovitz-Friedman A. Effects of extracellular matrix on the response of endothelial cells to radiation in vitro. European Journal of Cancer 1992; 28A: 725–731
   PubMed Web of Science ®Google Scholar
• Gille J. Antiangiogenic cancer therapies get their act together: Current developments and future prospects of growth factor – and growth factor receptor-targeted approaches. Experimental Dermatology 2006; 15: 175–186
   PubMed Web of Science ®Google Scholar
• Goel H L, Languino L R. Integrin signaling in cancer. Cancer Treatment and Research 2004; 119: 15–31
   PubMedGoogle Scholar
• Hanahan D, Weinberg R A. The hallmarks of cancer. Cell 2000; 100: 57–70
   PubMed Web of Science ®Google Scholar
• Hartwell L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 1992; 71: 543–546
   PubMed Web of Science ®Google Scholar
• Hehlgans S, Eke I, Deuse Y, Cordes N. Integrin-linked kinase: Dispensable for radiation survival of three-dimensionally cultured fibroblasts. 2007a, Radiotherapy and Oncology. 2007 Sept 28 [epub ahead of print]
   Google Scholar
• Hehlgans S, Haase M, Cordes N. Signalling via integrins: Implications for cell survival and anticancer strategies. Biochimica et Biophysica Acta 2007b; 1775: 163–180
   PubMed Web of Science ®Google Scholar
• Hess A R, Hendrix M J. Focal adhesion kinase signaling and the aggressive melanoma phenotype. Cell Cycle 2006; 5: 478–480
   PubMed Web of Science ®Google Scholar
• Hess F, Estrugo D, Fischer A, Belka C, Cordes N. Integrin-linked kinase interacts with caspase-9 and -8 in an adhesion-dependent manner for promoting radiation-induced apoptosis in human leukemia cells. Oncogene 2007; 26: 1372–1384
   PubMed Web of Science ®Google Scholar
• Hodkinson P S, Elliott T, Wong W S, Rintoul R C, Mackinnon A C, Haslett C, Sethi T. ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through beta1 integrin-dependent activation of PI3-kinase. Cell Death and Differentiation 2006; 13: 1776–1788
   PubMed Web of Science ®Google Scholar
• Hynes R O. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110: 673–687
   PubMed Web of Science ®Google Scholar
• Karamouzis M V, Grandis J R, Argiris A. Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas. Journal of the American Medical Association 2007; 298: 70–82
   PubMed Web of Science ®Google Scholar
• Kasahara T, Koguchi E, Funakoshi M, Aizu-Yokota E, Sonoda Y. Antiapoptotic action of focal adhesion kinase (FAK) against ionizing radiation. Antioxidants & Redox Signaling 2002; 4: 491–499
   PubMed Web of Science ®Google Scholar
• Kremer C L, Schmelz M, Cress A E. Integrin-dependent amplification of the G2 arrest induced by ionizing radiation. Prostate 2006; 66: 88–96
   PubMed Web of Science ®Google Scholar
• Lewis J M, Truong T N, Schwartz M A. Integrins regulate the apoptotic response to DNA damage through modulation of p53. Proceedings of the National Academy of Sciences of the USA 2002; 99: 3627–3632
   PubMed Web of Science ®Google Scholar
• Lin E H, Hui A Y, Meens J A, Tremblay E A, Schaefer E, Elliott B E. Disruption of Ca2+-dependent cell-matrix adhesion enhances c-Src kinase activity, but causes dissociation of the c-Src/FAK complex and dephosphorylation of tyrosine-577 of FAK in carcinoma cells. Experimental Cell Research 2004; 293: 1–13
   PubMed Web of Science ®Google Scholar
• Livant D L. Targeting invasion induction as a therapeutic strategy for the treatment of cancer. Current Cancer Drug Targets 2005; 5: 489–503
   PubMed Web of Science ®Google Scholar
• Lu B, Shinohara E T, Edwards E, Geng L, Tan J, Hallahan D E. The use of tyrosine kinase inhibitors in modifying the response of tumor microvasculature to radiotherapy. Technology in Cancer Research & Treatment 2005; 4: 691–698
   PubMed Web of Science ®Google Scholar
• Milas L, Raju U, Liao Z, Ajani J. Targeting molecular determinants of tumor chemo-radioresistance. Seminars in Oncology 2005; 32: S78–81
   PubMed Web of Science ®Google Scholar
• Mitra S K, Schlaepfer D D. Integrin-regulated FAK-Src signaling in normal and cancer cells. Current Opinion in Cell Biology 2006; 18: 516–523
   PubMed Web of Science ®Google Scholar
• Moeller B J, Dewhirst M W. HIF-1 and tumour radiosensitivity. British Journal of Cancer 2006; 95: 1–5
   PubMed Web of Science ®Google Scholar
• Moeller B J, Richardson R A, Dewhirst M W. Hypoxia and radiotherapy: Opportunities for improved outcomes in cancer treatment. Cancer Metastasis Reviews 2007; 26: 241–248
   PubMed Web of Science ®Google Scholar
• Mohan N, Meltz M L. Induction of nuclear factor kappa B after low-dose ionizing radiation involves a reactive oxygen intermediate signaling pathway. Radiation Research 1994; 140: 97–104
   PubMed Web of Science ®Google Scholar
• Nelson C M, Bissell M J. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annual Reviews of Cell and Developmental Biology 2006; 22: 287–309
   PubMed Web of Science ®Google Scholar
• Neta R. Cytokines in radioprotection and therapy of radiation injury. Biotherapy 1988; 1: 41–45
   PubMedGoogle Scholar
• Park C C, Bissell M J, Barcellos-Hoff M H. The influence of the microenvironment on the malignant phenotype. Molecular Medicine Today 2000; 6: 324–329
   PubMedGoogle Scholar
• Park C C, Zhang H, Pallavicini M, Gray J W, Baehner F, Park C J, Bissell M J. Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Research 2006; 66: 1526–1535
   PubMed Web of Science ®Google Scholar
• Paszek M J, Zahir N, Johnson K R, Lakins J N, Rozenberg G I, Gefen A, Reinhart-King C A, Margulies S S, Dembo M, Boettiger D, Hammer D A, Weaver V M. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005; 8: 241–254
   PubMed Web of Science ®Google Scholar
• Razani B, Woodman S E, Lisanti M P. Caveolae: From cell biology to animal physiology. Pharmacological Reviews 2002; 54: 431–467
   PubMed Web of Science ®Google Scholar
• Rodemann H P, Dittmann K, Toulany M. Radiation-induced EGFR-Signaling and control of DNA-damage repair. Int J Radiat Biol, to be accepted (TRAB-2007-IJRB-0163)
   Web of Science ®Google Scholar
• Rose R W, Grant D S, O'Hara M D, Williamson S K. The role of laminin-1 in the modulation of radiation damage in endothelial cells and differentiation. Radiation Research 1999; 152: 14–28
   PubMed Web of Science ®Google Scholar
• Ruifrok A C, McBride W H. Growth factors: Biological and clinical aspects. International Journal of Radiation Oncology Biology Physics 1999; 43: 877–881
   PubMed Web of Science ®Google Scholar
• Saksela O, Rifkin D B. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. Journal of Cell Biology 1990; 110: 767–775
   PubMed Web of Science ®Google Scholar
• Schmidt-Ullrich R K, Mikkelsen R B, Dent P, Todd D G, Valerie K, Kavanagh B D, Contessa J N, Rorrer W K, Chen P B. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene 1997; 15: 1191–1197
   PubMed Web of Science ®Google Scholar
• Schwartz M A, Assoian R K. Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. Journal of Cell Science 2001; 114: 2553–2560
   PubMed Web of Science ®Google Scholar
• Toulany M, Dittmann K, Kruger M, Baumann M, Rodemann H P. Radioresistance of K-Ras mutated human tumor cells is mediated through EGFR-dependent activation of PI3K-AKT pathway. Radiotherapy and Oncology 2005; 76: 143–150
   PubMed Web of Science ®Google Scholar
• Vlodavsky I, Korner G, Ishai-Michaeli R, Bashkin P, Bar-Shavit R, Fuks Z. Extracellular matrix-resident growth factors and enzymes: Possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Reviews 1990; 9: 203–226
   PubMed Web of Science ®Google Scholar
• Weaver V M, Gilbert P. Watch thy neighbor: Cancer is a communal affair. Journal of Cell Science 2004; 117: 1287–1290
   PubMed Web of Science ®Google Scholar
• Williams T M, Lisanti M P. Caveolin-1 in oncogenic transformation, cancer, and metastasis. American Journal of Physiology and Cell Physiology 2005; 288: C494–506
   PubMed Web of Science ®Google Scholar
• Wu M, Wu Z F, Merajver S D. Rho proteins and cell-matrix interactions in cancer. Cells, Tissues and Organs 2007; 185: 100–103
   PubMed Web of Science ®Google Scholar
• Yamada K M, Even-Ram S. Integrin regulation of growth factor receptors. Nature Cell Biology 2002; 4: E75–76
   PubMed Web of Science ®Google Scholar